Date
Tuesday, February 28th 2023 (09:30 - 18:30)
Location
Galileilaan 15, 2845 Niel, België
Language
English
Full programmeOrganised by
Sillar Clinical
Categories
Tags
Insights into the Belgian framework of CTR / CTIS
As of 31 January 2023, sponsors must submit all initial clinical trial applications under the Clinical Trial Regulation (CTR - (EU) No 536/2014) using the EU portal (Clinical Trials Information System – CTIS) and can no longer submit via the processes outlined in the Clinical Trials Directive.
As we approach this key date, at.las and Sillar Clinical are organizing an event for ATMP developers at which practical insights into the Belgian framework of CTR as well as implementation and practical use of CTIS will be discussed.
This event will be particularly of interest for companies developing ATMP and will be of interest for both academic institutions and commercial companies that want to learn more about the ins and outs of submitting a clinical trial application under CTR.
This event is supported by FAMHP who will be presenting and participating in the panel discussion. Want to learn more about the EMA structure and CTR? We already look forward to welcome you at the event on 28 February 2023!
Programme
09h30 - 10h00 - Welcome
10h00 - 10h30 - Regulatory Framework : working groups EMA & STA
10h30 - 11h30 - ATMP focus : classification and guidelines
11h30 - 12h00 - Q&A
12h00 - 13h00 - Lunch
13h00 - 14h00 - CTR and its implementation in Belgium
14h00 - 14h30 - Q&A
14h30 - 15h00 - Break
15h00 - 16h00 - Submission through CTIS
16h00 - 16h30 - Q&A
16h30 - 16h45 - The FAMHP perspective
16h45 - 17h30 - Panel discussion
17h30 - 18h30 - Networking drink